A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
暂无分享,去创建一个
C. Kartasasmita | E. Fadlyana | K. Rusmil | H. Sukandar | V. Setiawaty | Rodman Tarigan | Rini Mulia Sari | N. Bachtiar | Q. Gao | K. Pangesti | S. Sudigdoadi | C. Murad | Yalin Hu | A. Rahmadi | I. Megantara | S. Prodjosoewojo | Y. Sofiatin | R. M. Sari | C. V. Khrisna | Lilis Setyaningsih | F. Surachman | Kusnandi Rusmil